ArticleCytoskeleton (Hoboken, N.J.)2026
Molecular Insights Into the Differential Binding Affinity of Human Katanin Hexamer for C-Terminal Tails of β-Tubulin Isotypes.
Article in Cytoskeleton (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Insights Into the Differential Binding Affinity of Human Katanin Hexamer for C-Terminal Tails of β-Tubulin Isotypes.Cytoskeleton (Hoboken, N.J.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Katanin is a microtubule-severing enzyme critical for cellular processes such as cell division, migration, signaling, and cellular homeostasis. Katanin, a heterodimeric protein composed of p60 and p80, exhibits ATPase activity that is stimulated by microtubules and is responsible for removing tubulin subunits during severing. This severing function requires the assembly of katanin into a hexameric complex. Previous studies have demonstrated that katanin has a differential binding affinity towards C-terminal tails (CTTs) of β-tubulin isotypes. However, the interaction dynamics of human katanin hexamer with different β-tubulin isotypes-especially those overexpressed in various carcinomas-remain poorly understood at the atomic level. In this study, we employed homology modeling, docking, and molecular dynamics simulations to examine the binding behavior of the human katanin hexamer with the CTTs of five β-tubulin isotypes, which include βI, βIIa, βIII, βIVb, and βV. Our findings reveal that the katanin hexamer exhibits distinct interaction patterns with each isotype, attributed to their sequence-specific variations in the CTTs. Detailed MD analyses, including radius of gyration, solvent-accessible surface area, hydrogen bonding, principal component analysis, and free energy landscape profiling, further support these isoform-specific differences in the interaction dynamics. Moreover, binding free energy calculations indicate that the hexamer shows the highest affinity for βIIa, followed by βIII, βIVb, and βV, with the weakest interaction observed for βI. These computational insights underscore the mechanism of isoform-specific binding preferences of the human katanin hexamer toward β-tubulin CTTs, highlighting their potential implications for therapeutic targeting in cancer contexts where specific β-tubulin isotypes are upregulated.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.